Oscar Health Swung to a $1.10-a-Share Profit From a Loss a Year Ago. The Stock Jumped 17%

Oscar Health reported second-quarter 2026 earnings of $1.10 per share on August 6, 2026, against a Wall Street estimate of $0.49 and a loss in the same quarter a year earlier. Revenue came in at $4.88 billion, above the $4.75 billion analysts had modeled. The stock rose 17.2% in the ten minutes after the release and held that gain through the fifteen-minute mark — a sustained reaction, not a spike that faded.

Oscar Health sells individual health insurance plans, mostly through the ACA marketplace, a business model that has been unprofitable for most of the company's public history because insurers in that market must carefully price plans against a membership pool whose health costs are hard to predict in advance. A swing from loss to a meaningful per-share profit is not just a beat against estimates — it is evidence that the underlying pricing and medical-cost management is working at the current membership scale, not merely that one quarter happened to run favorably.

The company raised its full-year guidance alongside the results, a signal that management sees the improvement as continuing rather than a one-off quarter. For a marketplace insurer, the read-through that matters most is whether medical costs are staying inside what premiums were priced to cover — and a beat of this size, paired with a raised outlook, is the company's own answer to that question.